- SEK21.69bn
- SEK24.33bn
- €425.00m
Brief: Vimian Q3 Adjusted EBITA EUR 29.2 Million Vs. IBES Estimate EUR 28.2 Million
Brief: Vimian Group To Buy Norfolk Medical Products In US
Brief: Vimian Group To Issue And Repurchase Over 2.6 Mln Shares For LTIP 2026
Sweden's Vimian Q2 revenue, adjusted EBITA beat expectations
Brief: Vimian Q2 Adjusted EBITA EUR 29.7 Million Vs. IBES Estimate EUR 29.1 Million
Sweden's Vimian Q1 revenue beats on acquisitions boost
Brief: Vimian Q1 Adjusted EBITA EUR 29.2 Million Vs. IBES Estimate EUR 29.2 Million
Brief: Vimian Proposes To AGM In 2026 To Not Distribute Dividend For 2025
Brief: Vimian Acquires I-Vet
Brief: Vimian Group Appoints Alireza Tajbakhsh As CEO
Brief: Vimian Q3 Adjusted EBITA EUR 25.5 Million
Brief: Vimian Executive Sven Johan Magnus Göte Kjellberg Disposed SEK 2.2 Mln Worth Of Share
Europe Research Roundup: Alfen, Dermapharm Holding, Fugro
Brief: Vimian Q2 Adjusted EBITA EUR 25.4 Million
Brief: Vimian CEO Patrik Eriksson Steps Down
Brief: Vimian To Buy Allaccem Inc
Brief: Vimian Contemplates Issuance Of Senior Unsecured Bond
Brief: Vimian Group Q1 Adjusted EBITA Up At EUR 28.3 Mln
Brief: Vimian Q1 Adjusted EBITA EUR 28.3 Million